Not applicableStudy completedNCT01738776What this trial is testingNutritional Risk Factors for Hip Fracture: a Case Control StudyWho this might be right forHip Fracture Oslo University Hospital 184
Not applicableStudy completedNCT02762188What this trial is testingGenetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)Who this might be right forAge-Related Macular Degeneration Brugmann University Hospital 501
Not applicableLooking for participantsNCT06261346What this trial is testingPlasma Rich in Growth Factors in Corneal Endothelial TransplantationWho this might be right forFuchs' Endothelial DystrophyCorneal Edema University of Miami 100
Not applicableUnknownNCT05522270What this trial is testingConcentrated Growth Factor Versus Platelet Rich Fibrin in Revitalization of Necrotic Young Permanent IncisorsWho this might be right forNecrotic Pulp Ahmad Elheeny 60
Testing effectiveness (Phase 2)Study completedNCT00569673What this trial is testingDocetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Gynecologic Oncology Group 71
Large-scale testing (Phase 3)Ended earlyNCT00895479What this trial is testingAdenovirus Vascular Endothelial Growth Factor (VEGF) Therapy in Vascular Access - Novel Trinam AGainst Control EvidenceWho this might be right forEnd Stage Renal Disease Ark Therapeutics Ltd 250
Large-scale testing (Phase 3)Active Not RecruitingNCT04305496What this trial is testingCapivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast CancerWho this might be right forLocally Advanced (Inoperable) or Metastatic Breast Cancer AstraZeneca 818
Testing effectiveness (Phase 2)UnknownNCT02844283What this trial is testingAd-HGF Treatment for Myocardial InfarctionWho this might be right forMyocardial Infarction The First Affiliated Hospital with Nanjing Medical University 100
Post-approval studies (Phase 4)Study completedNCT01287754What this trial is testingTarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR MutationsWho this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 24
Testing effectiveness (Phase 2)Study completedNCT01031446What this trial is testingCisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast CancerWho this might be right forBreast Cancer Vanderbilt-Ingram Cancer Center 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT01362803What this trial is testingAZD6244 Hydrogen Sulfate for Children With Nervous System TumorsWho this might be right forNeurofibromatosis 1Neurofibromatosis Type 1NF1+1 more National Cancer Institute (NCI) 99
Testing effectiveness (Phase 2)Study completedNCT00612456What this trial is testingTo Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMDWho this might be right forMacular Degeneration GlaxoSmithKline 70
Not applicableStudy completedNCT03609125What this trial is testingCord Blood Serum in the Treatment of Neuro-Degenerative Ophthalmic Diseases. 1-GlaucomaWho this might be right forGlaucomaNeuro-Degenerative Disease IRCCS Azienda Ospedaliero-Universitaria di Bologna 20
Not applicableStudy completedNCT02424240What this trial is testingGrowth Hormone (GH) Deficiency & Insulin Like Growth Factor 1 (IGF-I)/ Insulin Like Growth Factor Binding Protein 3 (IGFBP-3) RatioWho this might be right forDiagnosis of GHD With IGF-I/IGFBP-3 Ratio University of Jordan 134
Not applicableNot Yet RecruitingNCT05850559What this trial is testingAssessment of the Diagnostic Role of Serum Insulin-like Growth Factor Binding Protein-3 as a Potential Biomarker for Colorectal Cancer (CRC) in EgyptWho this might be right forColorectal Cancer Assiut University 50
Early research (Phase 1)Ended earlyNCT01081808What this trial is testingLaboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid TumorsWho this might be right forNeoplasmsTumorsSolid Tumors+1 more Roger Williams Medical Center 2
Not applicableStudy completedNCT02175940What this trial is testingVEGF and PEDF in Patients With Myopic Choroidal NeovascularizationWho this might be right forMyopic Choroidal NeovascularizationVEGF Aqueous LevelPEDF Aqueous Level Università degli Studi di Brescia 40
Early research (Phase 1)Active Not RecruitingNCT02609776What this trial is testingStudy of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung CancerWho this might be right forNon-Small-Cell Lung Cancer Janssen Research & Development, LLC 751
Large-scale testing (Phase 3)WithdrawnNCT04978324What this trial is testingScaling and Root Planning With Localized Delivery of Autogenous Growth Factors- Platelet Rich Fibrin (PRF)Who this might be right forPeriodontitis Chronic Generalized SeverePeriodontitis Chronic Generalized Moderate Virginia Commonwealth University
Not applicableStudy completedNCT05678517What this trial is testingSeven-year Outcomes Following Intensive Anti-VEGF Therapy in Wet AMDWho this might be right forAge-Related Macular Degeneration Semmelweis University 47